U.S. News & World Report: Smoking residue on household surfaces can harm kids
Tobacco researcher Ashley Merianos leads study of thirdhand smoke in homes where children reside
A new study by UC tobacco researcher Ashley Merianos was featured in U.S. News & World Report.
The study measured the amount of nicotine and tobacco related toxins on surfaces in smoking households where children reside. The residue that remains on surfaces such as walls, tables, floors and decor is called thirdhand smoke.
Ashley Merianos is an associate professor in UC's school of Human Services
Merianos led a research team that tested homes of 84 children found nicotine on surfaces in every home, and nearly half had detectable levels of a tobacco-specific carcinogen called NNK. Residue was also found in households with indoor smoking bans.
"This is critically important and concerning," said Merianos, an associate professor in the College of Education, Criminal Justice and Human Services.
Merianos is a research affiliate member of Cincinnati Children’s Hospital Medical Center, the Thirdhand Smoke Research Consortium and the American Academy of Pediatrics Tobacco Consortium.
Featured image at top of cigarette and ashtray. Photo/iStock/Kotlyarchuk
Impact Lives Here
The University of Cincinnati is leading public urban universities into a new era of innovation and impact. Our faculty, staff and students are saving lives, changing outcomes and bending the future in our city's direction. Next Lives Here.
Related Stories
Pocket-sized population threat
June 10, 2026
The Financial Times took a deep dive into why populations around the world continue to be on the decline. The publication cited new University of Cincinnati research as part of the investigation that looks at the fall of fertility in the digital era.
Patients with developmental disabilities may benefit with an integrated care model
June 9, 2026
Researchers from the University of Cincinnati and Ohio State University have found that adults with developmental disabilities who have integrated care were less likely to go to the emergency room or be hospitalized than others who were not. Their work was published in Disability and Health Journal.
UC physician-researcher's work yields landmark five-year data for Crohn's disease drug
June 8, 2026
The University of Cincinnati College of Medicine’s Anita Afzali, MD, leads a landmark study revealing five-year efficacy and safety data for a Crohn’s disease drug called guselkumab.